Status:
WITHDRAWN
Effects of Dexmedetomidine on Tourniquet Pain Associated With Lower Extremity Surgeries Under General Anesthesia
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Orthopedic/Podiatry Procedures
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
This study is being done to determine if the drug known as dexmedetomidine improves the way we care for patients when their surgery involves the use of a tourniquet on the leg. A tourniquet is sometim...
Detailed Description
The study will be a prospective, randomized, double blinded, and placebo controlled clinical trial. The subject population will consist of patients ages 18 to 80 undergoing same day, lower extremity s...
Eligibility Criteria
Inclusion
- Patients undergoing lower extremity surgery which requires the use of an inflated tourniquet ASA rating I-III
Exclusion
- Allergy to alpha 2 adrenergic agonists
- Uncontrolled hypertension (SBP\>180mm HG, Diastolic Blood Pressure \>110mmHG)
- Heart block greater than first degree or cardiac muscle at risk for reversible ischemia
- Airway anatomy that contra-indicates the use of a laryngeal airway mask expected tourniquet time less than 60 minutes or greater than 150 minutes
- Subjects who do not have a phone
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00932386
Start Date
July 1 2009
Last Update
April 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New Jersey Medical School
Newark, New Jersey, United States, 07101